ROMAPHARM
Board
3 directors, 1 in day-to-day management, last change in 2025O.P.S. BV
Director and managing director, permanent representative Geert Decru
appointed by deed of 06-08-2025
term until the 2031 general meeting
also on the board of 1 other company
listed in the 2025 annual accounts, filed on 10-06-2026
DEMARAX BV
Director, permanent representative HOUVENAGHEL Pascale
in office according to the deed of 09-05-2022
6-year term from 2022
also on the board of 1 other company
listed in the 2025 annual accounts, filed on 10-06-2026
Director
in office according to the deed of 09-05-2022
term until the 2031 general meeting
listed in the 2025 annual accounts, filed on 10-06-2026
- Day-to-day management
- O.P.S.
Permanent representatives 2
HOUVENAGHEL Pascale
Permanent representative, for DEMARAX
in office according to the deed of 09-05-2022
Mandates through the years
4 names, the dashed line is todayLeadershipBoardEarlierRest of the termmandate already running before its first mention
Mandates as a list
- DEMARAX
- Director, since before 31-12-2021
- Marceau DECRU
- Director, since before 31-12-2021
- O.P.S.
- Director, since before 31-12-2021
- Managing director, appointed by deed of 06-08-2025, still in office
- Geert Decru
- Director, from before 31-12-2021 to 21-03-2025
Control
Capital
- Capital
- €172,000
- Shares
- 250
- Contribution per share
- €688
- Equity per share
- €9,134 in 2025
- Source
- deed of 09-05-2022
Articles of association
deed of 09-05-2022 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Friday of June at 17:00